The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
Launched by BOSTON CHILDREN'S HOSPITAL · Oct 19, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Patient and Family Centered I-PASS LISTEN Study is looking to improve how medical teams communicate with patients and their families in hospitals, especially for those who speak languages other than English. Originally developed in 2014, the PFC I-PASS program changed how doctors and nurses talk to patients during their daily check-ups, making conversations more inclusive and easier to understand. This new study, called PFC I-PASS+, builds on that program by adding interpreters and training for healthcare providers on better communication and understanding different cultures. The goal is to see if this new approach can help improve the hospital experience and safety for patients.
To participate in the study, patients admitted to pediatric units at certain hospitals can join, especially if they are 13 years or older with permission from a parent or guardian. Parents or caregivers of patients, nurses, doctors in training, and hospital leaders are also eligible to take part. Participants can expect to be involved in discussions about their care and will receive support in their preferred language. This study aims to ensure that everyone involved in a patient's care feels included and understood, no matter what language they speak.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients admitted to the pediatric inpatient study units of participating hospitals
- • Patients themselves who are age 13 and up (if they provide assent and their parent or guardian gives permission)\*
- • Parents/caregivers of patients of all ages who speak English, Arabic, Armenian, Bengali, Chinese (Mandarin and Cantonese), Karen, Korean, Nepali, Quiche, Spanish, Somali, and Vietnamese (and/or other languages if resources allow)
- • Nurses working on these units
- • Residents working on these units
- • Medical and nursing students working on these units
- • Hospital leaders working at these hospitals
- • \*Note for Consenting: Patients (13-18yo) who are in state custody and assent for themselves to complete surveys but lack legal guardian/caregiver present to offer consent are not being approached to complete surveys. These patients may still be enrolled in the study but not consented to complete patient-facing forms.
- • Exclusion Criteria: None
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Los Angeles, California, United States
Birmingham, Alabama, United States
Omaha, Nebraska, United States
Bronx, New York, United States
Pittsburgh, Pennsylvania, United States
Amarillo, Texas, United States
Oakland, California, United States
Columbus, Ohio, United States
Patients applied
Trial Officials
Alisa Khan, MD, MPH
Principal Investigator
Boston Children's Hospital/Harvard Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials